Current State of Knowledge on Aetiology, Diagnosis, Management, and Therapy of Peripartum Cardiomyopathy: A Position Statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathyKaren Sliwa, John J.V. McMurray, Denise Hilfiker‐Kleiner et al.|European Journal of Heart Failure|2010Cited by 1.1k
Shared Genetic Predisposition in Peripartum and Dilated CardiomyopathiesJames S. Ware, Zoltàn Arany, Jian Li et al.|New England Journal of Medicine|2016Cited by 597
Pathophysiology, Diagnosis and Management of Peripartum Cardiomyopathy: A Position Statement from the Heart Failure Association of the European Society of Cardiology Study Group on Peripartum CardiomyopathyJohann Bauersachs, Karen Sliwa, Tobias König et al.|European Journal of Heart Failure|2019Cited by 435
Phenotyping and outcome on contemporary management in a German cohort of patients with peripartum cardiomyopathyAiden Haghikia, Denise Hilfiker‐Kleiner, Edith Podewski et al.|Basic Research in Cardiology|2013Cited by 351
Bromocriptine for the treatment of peripartum cardiomyopathy: a multicentre randomized studyDenise Hilfiker‐Kleiner, Johann Bauersachs, Uwe Kühl et al.|European Heart Journal|2017Cited by 334